Autres langues IRIDEX Corporation

Actions

IRIX

US4626841013

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 15/04/2024			Varia. 5j.	Varia. 1 janv.
3,17 ^USD	-5,37 %		-10,20 %	+12,81 %

26/03	Transcript : IRIDEX Corporation, Q4 2023 Earnings Call, Mar 26, 2024
26/03	IRIDEX Corporation annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Iridex: Q4 Earnings Snapshot	26/03
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q4 Revenue $12.5M, vs. Street Est of $14.9M	26/03
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	26/03
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results	26/03
IRIDEX Corporation Reports Earnings Results for the Fourth Quarter Ended December 30, 2023	26/03
North American Morning Briefing : Markets Steady -2-	26/03
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024	20/03
Iridex Corporation Receives European Patent on MicroPulse Technology	06/02
Iridex Corporation Receives European Patent on MicroPulse Technology	06/02
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust	24/01
Iridex Corporation Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust	24/01
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma	12/01
Iridex Corporation Launches New Iridex 532 and Iridex 577 Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma	12/01
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation	29/12
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	27/11
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	27/11
Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation	27/11
Iridex: Q3 Earnings Snapshot	14/11
Earnings Flash (IRIX) IRIDEX CORPORATION Reports Q3 Revenue $12.9M, vs. Street Est of $13.5M	14/11
Iridex Reports Third Quarter 2023 Financial Results and Business Update	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues IRIDEX Corporation

Actions

IRIX

US4626841013

Autres langues

Filtres